Minnesota

Showing 1-7 of 7 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Hybrid Closed Loop Therapy for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study (CLVerEX)	Regents of the University of Minnesota	Antoinette Moran	Cures	01-April-2023 to 31-March-2026	$1,739,442.00
Mechanistic Etiologies Underlying the Impact of Verapamil to Preserve β Cell Function in Type 1 diabetes	Regents of the University of Minnesota	Antoinette Moran	Cures	01-September-2024 to 31-August-2026	$643,946.00
Growing Beta Cell Replacement in T1D by Tolerizing Stem Cell-Derived Islets	Regents of the University of Minnesota	Bernhard Hering	Cures	01-August-2025 to 31-July-2027	$688,430.02
Employing PD-L1-Modified Biomaterials to Induce Islet Allograft Tolerance Following Perihepatic Transplantation in Nonhuman Primates	Regents of the University of Minnesota	Melanie Graham	Cures	01-April-2025 to 31-March-2027	$918,744.88
Colonic Delivery of Butyrate to Improve Insulin Sensitivity and Lower Triglycerides in Type 1 Diabetes Patients	Mayo Clinic	Adrian Vella	Improving Lives	01-October-2019 to 31-March-2025	$365,991.93
Controlling cytoarchitecture and function in novel stem-cell-based implants intended for T1D therapy	Mayo Clinic	Quinn Peterson	Cures	01-February-2026 to 31-January-2028	$600,000.00
Optimizing islet cell graft performance with targeted alpha and beta cell composition and distribution	Mayo Clinic	Quinn Peterson	Cures	01-April-2025 to 31-March-2027	$699,138.64